EUVIMEDEUVIMED entdecken
Crossref

Probiotic Supplementation with BLa80, BL21, and LRa05 Improves Gut Microbiota in Chronic Hepatitis B Patients Receiving Tenofovir Alafenamide: A Randomized, Double-Blind, Placebo-Controlled Trial

Long Jianfei, Wang Li, Xiang Xi, Wei Lanyi, He Tianye, Wang Jinyu, Chi Xiangyu, Hu Tiantian, Jia Yidi, Li Ling, Gao Yuan, Zhu Haoxiang und 2 weitere

Probiotics and Antimicrobial Proteins · 2026-06 · 18 (5) · 7508-7519

DOI: 10.1007/s12602-026-10945-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Probiotics and Antimicrobial Proteins, online erschienen am 11.03.2026. Verfasst von Long Jianfei und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Huashan Hospital, Fudan University, Shanghai, China. longjianfei@huashan.org.cn. Die Arbeit nennt 28 Literaturangaben. Gefördert von: National Natural Science Foundation of China, 2023 Shanghai “Rising Stars of Medical Talents” Youth Development Program, the 2nd Session of the 2023 Annual Shanghai Young Pharmaceutical Talents Capability Enhancement Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

DysbiosisGut-liver axisMetabolic dysfunctionMicrobial therapeuticsViral hepatitis

Autor:innen und Institutionen

  • Department of Pharmacy, Huashan Hospital, Fudan University, Shanghai, China. longjianfei@huashan.org.cn.
  • Department of Pharmacy, Huashan Hospital, Fudan University, Shanghai, China.
  • The Faculty of Medicine, Qilu Institute of Technology, Jinan, 250200, China.
  • Department of Infectious Diseases, Huashan Hospital, Fudan University, No.12 Middle Wu Lu Mu Qi Road, Shanghai, 200040, China.
  • Department of Pharmacy, Jing'an District Central Hospital, Fudan University, Shanghai, China.
  • Department of Pharmacy, Yichang Central People's Hospital, Hubei, China.

Förderung

  • National Natural Science Foundation of China
  • 2023 Shanghai “Rising Stars of Medical Talents” Youth Development Program
  • the 2nd Session of the 2023 Annual Shanghai Young Pharmaceutical Talents Capability Enhancement Program

Zitieren

APA

Jianfei, L., Li, W., Xi, X., Lanyi, W., Tianye, H., Jinyu, W., Xiangyu, C., Tiantian, H., Yidi, J., Ling, L., Yuan, G., Haoxiang, Z., Jiming, Z., & Bin, W. (2026). Probiotic Supplementation with BLa80, BL21, and LRa05 Improves Gut Microbiota in Chronic Hepatitis B Patients Receiving Tenofovir Alafenamide: A Randomized, Double-Blind, Placebo-Controlled Trial. Probiotics and Antimicrobial Proteins, 18(5), 7508-7519. https://doi.org/10.1007/s12602-026-10945-8

Vancouver

Jianfei L, Li W, Xi X, Lanyi W, Tianye H, Jinyu W, et al. Probiotic Supplementation with BLa80, BL21, and LRa05 Improves Gut Microbiota in Chronic Hepatitis B Patients Receiving Tenofovir Alafenamide: A Randomized, Double-Blind, Placebo-Controlled Trial. Probiotics and Antimicrobial Proteins. 2026;18(5):7508-7519. doi:10.1007/s12602-026-10945-8

BibTeX
@article{Jianfei2026,
  author = {Jianfei, Long and Li, Wang and Xi, Xiang and Lanyi, Wei and Tianye, He and Jinyu, Wang and Xiangyu, Chi and Tiantian, Hu and Yidi, Jia and Ling, Li and Yuan, Gao and Haoxiang, Zhu and Jiming, Zhang and Bin, Wang},
  title = {Probiotic Supplementation with BLa80, BL21, and LRa05 Improves Gut Microbiota in Chronic Hepatitis B Patients Receiving Tenofovir Alafenamide: A Randomized, Double-Blind, Placebo-Controlled Trial},
  journal = {Probiotics and Antimicrobial Proteins},
  year = {2026},
  volume = {18},
  number = {5},
  pages = {7508--7519},
  doi = {10.1007/s12602-026-10945-8}
}
Kostenlos starten →